Document is current

Article History

Received: 6 September 2022

Accepted: 14 October 2022

First Online: 5 November 2022

Declarations

:

: The author Marlene Maßmann declares no conflict of interest. The co-author Stefan Kasper discloses honoraria (self) from Merck, Amgen, Roche, Sanofi, Aventis, Servier, and Lilly; honoraria (institution) from Merck, Amgen, Roche, and Lilly; advisory/consultancy roles with Merck, Amgen, Roche, Sanofi, Aventis, Servier, and Lilly; research Grants/funding (self) from Merck and Lilly; research Grants/funding (institution) from Merck and Lilly; travel/accommodation expenses from Merck, Amgen, Roche, Sanofi, Aventis, Servier, and Lilly. The co-author Martin Schuler discloses honoraria (consultant) from Amgen, AstraZeneca, BIOCAD, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck Serono, Novartis, Roche, Sanofi, Takeda; honoraria for CME presentations from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Novartis; research funding (institution) from AstraZeneca, Bristol Myers-Squibb. The co-author Marcel Wiesweg discloses honoraria: Amgen, Boehringer Ingelheim, Novartis, Roche, Takeda; research funding: Bristol-Myers Squibb, Takeda. The co-author Jens T. Siveke discloses honoraria (consultant or for continuing medical education) presentations from AstraZeneca, Bayer, Immunocore, Roche, Servier; research grants/funding (institution) from Bristol-Myers Squibb, Celgene, Roche; he holds ownership and serves on the Board of Directors of Pharma15. All remaining authors declared no conflict of interest.

: The study was approved by the Ethics Committee of the Medical Faculty of the University Duisburg-Essen (Project No. 15-6497).